Literature DB >> 25998045

Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients.

Saurabh Priyadarshi1, Chinmay Sundar Ray2, Narayan Chandra Biswal2, Soumya Ranjan Nayak3, Khirod Chandra Panda4, Ashim Desai5, Puppala Venkat Ramchander1.   

Abstract

Otosclerosis (OTSC) is a late-onset hearing disorder characterized by increased bone turnover in the otic capsule. Disturbed osteoprotegerin expression has been found in the otosclerotic foci which may have an important role in the pathogenesis of OTSC. To identify the genetic risk factors, we sequenced the coding region and exon-intron boundaries of the OPG gene in 254 OTSC patients and 262 controls. Sequence analysis identified five known polymorphisms c.9C>G, c.30+15C>T, c.400+4C>T, c.768A>G, and c.817+8A>C. Testing of these SNPs revealed sex specific association with c.9C>G in males and c.30+15C>T in females after multiple correction. Furthermore, meta-analysis provided evidence of association of the c.9C>G polymorphism with OTSC. In secondary analysis, we investigated the mRNA expression of OPG and associated genes RANK and RANKL in otosclerotic tissues compared to controls. Expression analysis revealed significantly missing/reduced OPG expression only in otosclerotic tissues. However, the signal sequence polymorphism c.9C>G has shown no effect on OPG mRNA expression. In conclusion, our results suggest that the risk of OTSC is influenced by variations in the OPG gene along with other factors which might regulate its altered expression in otosclerotic tissues. Further research is warranted to elucidate the mechanisms underlying these observations.
© 2015 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  Otosclerosis; mRNA expression; osteoprotegerin; otic capsule; polymorphisms

Mesh:

Substances:

Year:  2015        PMID: 25998045     DOI: 10.1111/ahg.12118

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  5 in total

1.  A wide range of protective and predisposing variants in aggrecan influence the susceptibility for otosclerosis.

Authors:  Allan Thomas Højland; Lisse J M Tavernier; Guy Van Camp; Erik Fransen; Isabelle Schrauwen; Manou Sommen; Vedat Topsakal; Isabelle Schatteman; Ingeborg Dhooge; Alex Huber; Diego Zanetti; Henricus P M Kunst; Alexander Hoischen; Michael B Petersen
Journal:  Hum Genet       Date:  2021-08-19       Impact factor: 4.132

Review 2.  Genetics of otosclerosis: finally catching up with other complex traits?

Authors:  Lisse J M Tavernier; Erik Fransen; Hanne Valgaeren; Guy Van Camp
Journal:  Hum Genet       Date:  2021-09-09       Impact factor: 4.132

3.  The risks of RELN polymorphisms and its expression in the development of otosclerosis.

Authors:  Saurabh Priyadarshi; Kirtal Hansdah; Neha Singh; Amal Bouzid; Chinmay Sundar Ray; Khirod Chandra Panda; Narayan Chandra Biswal; Ashim Desai; Jyotish Chandra Choudhury; Adel Tekari; Saber Masmoudi; Puppala Venkat Ramchander
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

4.  Genetic Association of rs1021188 and DNA Methylation Signatures of TNFSF11 in the Risk of Conductive Hearing Loss.

Authors:  Amal Bouzid; Ameni Chelly; Adel Tekari; Neha Singh; Kirtal Hansdah; Imen Achour; Ikhlas Ben Ayed; Fida Jbeli; Ilhem Charfeddine; Puppala Venkat Ramchander; Rifat Hamoudi; Saber Masmoudi
Journal:  Front Med (Lausanne)       Date:  2022-04-18

5.  Otosclerosis Associated with a De Novo Mutation -832G > A in the TGFB1 Gene Promoter Causing a Decreased Expression Level.

Authors:  Saurabh Priyadarshi; Kirtal Hansdah; Chinmay Sundar Ray; Narayan Chandra Biswal; Puppala Venkat Ramchander
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.